LIGAND PHARMACEUTICALS INC

Ticker: LGND CUSIP: 53220K504 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 6,033 Value ($000) $1,141 Avg Close $192.14 Range $175.56 - $212.49
Q1 2025
Shares 2,944 Value ($000) $310 Avg Close $113.09 Range $102.79 - $125.17
Q4 2024
Shares 23,763 Value ($000) $2,546 Avg Close $113.04 Range $97.78 - $129.90
Q3 2024
Shares 26,963 Value ($000) $2,699 Avg Close $100.67 Range $81.74 - $112.13
Q2 2024
Shares 17,296 Value ($000) $1,457 Avg Close $79.57 Range $67.72 - $88.73
Q1 2024
Shares 24,224 Value ($000) $1,771 Avg Close $73.72 Range $67.53 - $94.57
Q1 2020
Shares 3,425 Value ($000) $249 Avg Close $56.68 Range $35.71 - $76.16
Q4 2018
Shares 8,825 Value ($000) $1,198 Avg Close $106.61 Range $79.98 - $173.81
Q3 2018
Shares 900 Value ($000) $247 Avg Close $150.76 Range $127.91 - $172.25
Q4 2014
Shares 6,900 Value ($000) $367 Avg Close $32.53 Range $26.19 - $36.48
Q3 2014
Shares 12,000 Value ($000) $564 Avg Close $33.19 Range $28.90 - $40.96
Q2 2014
Shares 17,200 Value ($000) $1,141 Avg Close $40.58 Range $34.87 - $44.57
Q1 2014
Shares 49,400 Value ($000) $3,668 Avg Close $41.68 Range $31.65 - $50.17